Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination

Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the second dose. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ya‐ting, Wang, Shang‐shang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349810/
https://www.ncbi.nlm.nih.gov/pubmed/35941937
http://dx.doi.org/10.1002/ski2.139
Descripción
Sumario:Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the second dose. He had poor effect and liver function impairment developed after acitretin used, but achieved satisfactory efficacy after replacement to ixekizumab, an interleukin‐17A inhibitor.

Ejemplares similares